EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSBBBG00000007374
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSBBBG00000012809
Gene Symbol: KIF5B
3 Cross references
288 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSBBBG00000023666
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSBBBG00000003619
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSBBBG00000025500
Gene Symbol: LOXL2
3 Cross references
288 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSBBBG00000014247
Gene Symbol: MST1R
3 Cross references
268 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSBBBG00000001362
Gene Symbol: MGAM
3 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSBBBG00000005557
Gene Symbol: MMP1
3 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSBBBG00000020578
Gene Symbol: MMP12
3 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSBBBG00000020565
Gene Symbol: MMP13
3 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSBBBG00000023905
Gene Symbol: MMP14
3 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSBBBG00000009312
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).